title: Hepatocellular Carcinoma: Therapeutic Guidelines and Medical Treatment.
abstract: Western and Eastern perspectives on therapeutic guidelines for hepatocellular carcinoma (HCC) have many commonalities but may also differ in certain aspects, as described in this article. In view of the limited therapeutic options for advanced HCC, evidence-based therapies are few, and thus there is a dependence on consensus-based guidelines. This article focuses on the Italian Association for the Study of the Liver guidelines and the Japanese approaches to therapy, while drawing attention to certain controversies from other academic bodies where applicable and appropriate.
authors.affiliation: Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, OsakaSayama, Japan.
authors.forename: Masatoshi
authors.initials: M
authors.lastname: Kudo
authors.affiliation: Semeiotic Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna, Bologna, Italy.
authors.forename: Franco
authors.initials: F
authors.lastname: Trevisani
authors.affiliation: Memorial Sloan Kettering Cancer Center, N.Y., USA; Weill Cornell Medical College, N.Y., USA.
authors.forename: Ghassan K
authors.initials: GK
authors.lastname: Abou-Alfa
authors.affiliation: Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, Milan, Italy.
authors.forename: Lorenza
authors.initials: L
authors.lastname: Rimassa
keywords: Hepatocellular carcinoma; Practice guideline; Treatment; Treatment algorithm